- Record revenue of $1.7 billion, a 10% increase from Q2 2024.
- Record average daily volume of 30.2 million contracts, a 16% increase year-over-year.
- 57% increase in new retail traders contributing to record Micros ADV of 4.1 million contracts.
CME Group (CME, Financial) has announced its financial results for the second quarter of 2025, reporting record-breaking metrics across several key areas. The company achieved a record revenue of $1.7 billion, marking a 10% year-over-year growth. This was accompanied by an all-time high average daily volume (ADV) of 30.2 million contracts, a 16% increase compared to Q2 2024.
The company reported an operating income of $1.1 billion and net income of $1.0 billion. Adjusted net income reached $1.1 billion, with adjusted diluted earnings per share of $2.96. A substantial 57% rise in new retail traders contributed to a record Micros ADV of 4.1 million contracts, highlighting the company's success in expanding its user base.
As of June 30, 2025, CME Group maintained a robust financial position with $2.2 billion in cash and $3.4 billion in debt. Since the introduction of its variable dividend policy in 2012, CME has returned approximately $29.1 billion to shareholders, including $3.0 billion in dividends in the first half of 2025.
Furthermore, CME Group remains a formidable player in the derivatives marketplace, with a portfolio of global benchmark products that attract clients seeking risk management solutions across various asset classes. The company's strong quarter is indicative of its strategic initiatives and diversified product offerings resonating with a wide client base.
